Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide.
$31.28+0.90%
报价 2026-11-13
市值
$13.09B
EV
$16.54B
PE (TTM)
22.0x
预期 PE
–
52 周区间距高点 -15.2%
$26.42$36.90
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Devices| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| SNNSmith & Nephew plc | $13.09B | +0.9% | – | 68% | 22.0x | 10.3x | – | |
| GKOSGlaukos Corporation | $14.55B | -0.1% | +56.0% | 85.2% | – | – | 392.4x | 高增长 |
| PENPenumbra, Inc. | $12.65B | +0.0% | +15.9% | 67.1% | 74.0x | 59.0x | 63.1x | |
| ALGNAlign Technology, Inc. | $11.86B | +0.8% | +2.6% | 68.7% | 25.0x | 14.9x | 20.1x | |
| PODDInsulet Corporation | $10.58B | +2.1% | +22.8% | 70.2% | 24.8x | 15.1x | 30.9x | GARP |
| BIOBio-Rad Laboratories, Inc. | $9.85B | -1.1% | +0.4% | 51.9% | 9.4x | 9.6x | 29.9x | |
| BIO-BBio-Rad Laboratories, Inc. | $9.71B | -4.1% | +0.4% | 51.9% | 46.9x | 20.9x | 29.8x | |
| GMEDGlobus Medical, Inc. | $9.57B | -0.2% | +6.7% | 67.4% | 21.9x | 13.9x | 12.7x | |
| BRKRBruker Corporation | $9.41B | +2.1% | +3.4% | 49.1% | – | 90.1x | 38.9x | |
| 同行中位数 | – | – | +5.1% | 67.3% | 24.9x | 15.1x | 30.4x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。